VitaNova Life Sciences (VNOV) EBIT Growth (3y) (2020 - 2026)
VitaNova Life Sciences (VNOV) EBIT Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 29.94% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 26.79% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -3.82% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 1.32% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 20.42% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -1.54% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 85.70% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 6.25% |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | 57.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 57.43% |
| Oct 31, 2025 | 236.57% |
| Jul 31, 2025 | -158.14% |
| Apr 30, 2025 | 723.63% |
| Jan 31, 2025 | 62.93% |
| Oct 31, 2024 | 59.89% |
| Jul 31, 2024 | -63.00% |
| Apr 30, 2024 | 225.02% |
| Jan 31, 2024 | 59.42% |
| Oct 31, 2023 | 10.92% |
| Jul 31, 2023 | -29.18% |
| Apr 30, 2023 | 44.99% |
| Jan 31, 2023 | -55.05% |
| Oct 31, 2022 | 28.73% |
| Jul 31, 2022 | 27.56% |
| Apr 30, 2022 | 26.79% |
| Jan 31, 2022 | 39.01% |
| Oct 31, 2021 | -54.96% |
| Jul 31, 2021 | -26.62% |
| Oct 31, 2020 | -60.61% |